(Q33379717)

26 July 2017

1 reference

title

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme? (English)

1 reference

26 July 2017

1 reference

2

Anne Husebekk

1 reference

26 July 2017

Jens Kjeldsen-Kragh

1

1 reference

26 July 2017

Mette Kjaer Killie

series ordinal

3

1 reference

26 July 2017

Bjørn Skogen

series ordinal

4

1 reference

26 July 2017

publication date

21 May 2008

1 reference

Transfusion and Apheresis Science

26 July 2017

published in

1 reference

26 July 2017

volume

38

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

183-188

1 reference

The management of alloimmune neonatal thrombocytopenia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

348 cases of suspected neonatal alloimmune thrombocytopenia

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Prevalence and outcome of intracranial haemorrhage in haemophiliacs--a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Alloimmunization to the PlA1 platelet antigen: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Fetal thrombocytopenia and its relation to maternal thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Antenatal screening for human platelet antigen‐1a: results of a prospective study at a large maternity hospital in Ireland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Maternal alloimmunization against fetal platelet antigens: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Thrombocytopenia in term infants: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Neonatal thrombocytopenia: incidence, serological and clinical observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Neonatal and maternal thrombocytopenia: incidence and immune background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.04.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2008.04.010

1 reference

26 July 2017

1 reference